Page last updated: 2024-08-21

isoxazoles and Liposarcoma, Myxoid

isoxazoles has been researched along with Liposarcoma, Myxoid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abou Merhi, R; Agaimy, A; Al-Halabi, R; Aman, P; Gali-Muhtasib, H; Haller, F; Huebner, K; Schneider-Stock, R; Steinmann, S	1

Other Studies

1 other study(ies) available for isoxazoles and Liposarcoma, Myxoid

Article	Year
Hsp90 inhibition by AUY922 as an effective treatment strategy against myxoid liposarcoma. Cancer letters, 2015, Oct-28, Volume: 367, Issue:2 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; G2 Phase Cell Cycle Checkpoints; HCT116 Cells; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Liposarcoma, Myxoid; MAP Kinase Signaling System; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Resorcinols; Time Factors; Xenograft Model Antitumor Assays	2015

Article

Year

Hsp90 inhibition by AUY922 as an effective treatment strategy against myxoid liposarcoma.

Cancer letters, 2015, Oct-28, Volume: 367, Issue:2

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; G2 Phase Cell Cycle Checkpoints; HCT116 Cells; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Liposarcoma, Myxoid; MAP Kinase Signaling System; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Resorcinols; Time Factors; Xenograft Model Antitumor Assays

2015